Table 1 Baseline demographics and disease characteristics^ab

Sex at birth, n (%), female

51 (85.0)

Age, years

57.9 ± 9.25

Body mass index, kg/m²

31.0 ± 6.13

Race, n (%)

 White

53 (88.3)

 Asian

2 (3.3)

 American Indian/Alaska Native

0 (0)

 Black/African American

4 (6.7)

 Other

1 (1.7)

Ethnicity, n (%)

 Not Hispanic or Latino

49 (81.7)

Duration of RA diagnosis, years

14.6 ± 10.78

hsCRP, mg/L

7.93 ± 11.98

RF positive, n (%)

29 (48.3)

ACPA positive, n (%)

32 (53.3)

Number of prior b/ts DMARDs

2.5 ± 1.96

Number of prior b/ts DMARDs

 1

27 (45.0%)

 2

10 (16.7%)

 ≥3

23 (38%)

Prior b/ts DMARDs

 Anti-IL-1 agents

2 (3.3%)

 Anti-IL-6 agents

13 (21.7%)

 Anti-TNF agents

55 (91.7%)

 B-cell depleting agents

7 (11.7%)

 JAKi

8 (13.3%)

 CTLA4-Ig

18 (30.0%)

DAS28(CRP)

5.3 ± 0.88

CDAI

37.9 ± 12.24

SJC28

11.0 ± 5.57

TJC28

14.6 ± 6.99

HAQ-DI

1.4 ± 0.55